Related Experiment Video
Updated: Aug 13, 2026
10:23
Covalent Binding of BMP-2 on Surfaces Using a Self-assembled Monolayer Approach
Published on: August 26, 2013
Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration
J O Hollinger1, J M Schmitt, D C Buck
1Oregon Health Sciences University, Division of Plastic and Reconstructive Surgery, Portland 97201-3098, USA. hollinge@ohsu.edu
Journal of Biomedical Materials Research
|December 17, 1998
Summary
Recombinant human bone morphogenetic protein-2 combined with collagen effectively regenerated bone in rabbit defects. This combination therapy shows promise for treating segmental bone defects.
Area of Science:
- Biomaterials Science
- Orthopedic Surgery
- Regenerative Medicine
Background:
- Bone defects pose significant clinical challenges.
- Current treatments for critical-sized bone defects have limitations.
- rhBMP-2/collagen shows potential for bone regeneration.
Purpose of the Study:
- To evaluate the efficacy of recombinant human bone morphogenetic protein-2 combined with collagen (rhBMP-2/C) for bone regeneration.
- To compare rhBMP-2/C treatment with autograft and collagen alone in critical-sized defects.
Main Methods:
- Critical-sized defects were created in rabbit radii.
- Treatments included autograft, absorbable collagen (C), rhBMP-2/C, and untreated defects.
- Radiographic and histological analyses were performed at 4 and 8 weeks.
Main Results:
- rhBMP-2/C demonstrated a time-dependent increase in bone radiopacity.
- Histological examination confirmed osseous regeneration with rhBMP-2/C by 8 weeks.
- rhBMP-2/C and autograft groups showed significantly more new bone formation than control groups.
Conclusions:
- rhBMP-2/C is an effective therapy for regenerating bone in critical-sized defects.
- This combination promotes significant bone formation compared to collagen alone or untreated defects.
- rhBMP-2/C represents a promising alternative for treating segmental bone defects.
